When studying patients with NAFLD, Xu et al. suggested that patients without obesity have lower levels of AST and ALT than do those with obesity [24]; this observation may explain our finding pertaining to the lower levels of AST and ALT in Group N than in Group C. We observed a greater amelioration of hepatic steatosis and inflammation in Group NA than in Group N. These findings suggested that dehulled adlay decelerates the progression of NAFLD. The gene discussed is GPT; the disease is obesity disorder.